Vadim S Koshkin
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer (NCT07217496) | Vadim S Koshkin | 2026-02-15 |
| Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer (NCT05113537) | Vadim S Koshkin | 2022-07-08 |
Track Vadim S Koshkin automatically
Every clearance here is in the API, with alerts when new ones post.